Glaeser H - Search Results

1

P-glycoprotein-mediated intestinal and biliary digoxin transport in humans.

Drescher S, Glaeser H, Mürdter T, Hitzl M, Eichelbaum M, Fromm MF. Drescher S, et al. Among authors: glaeser h. Clin Pharmacol Ther. 2003 Mar;73(3):223-31. doi: 10.1067/mcp.2003.27. Clin Pharmacol Ther. 2003. PMID: 12621387

2

Influence of rifampicin on the expression and function of human intestinal cytochrome P450 enzymes.

Glaeser H, Drescher S, Eichelbaum M, Fromm MF. Glaeser H, et al. Br J Clin Pharmacol. 2005 Feb;59(2):199-206. doi: 10.1111/j.1365-2125.2004.02265.x. Br J Clin Pharmacol. 2005. PMID: 15676042 Free PMC article. Clinical Trial.

3

Induction of intestinal P-glycoprotein by St John's wort reduces the oral bioavailability of talinolol.

Schwarz UI, Hanso H, Oertel R, Miehlke S, Kuhlisch E, Glaeser H, Hitzl M, Dresser GK, Kim RB, Kirch W. Schwarz UI, et al. Among authors: glaeser h. Clin Pharmacol Ther. 2007 May;81(5):669-78. doi: 10.1038/sj.clpt.6100191. Epub 2007 Mar 28. Clin Pharmacol Ther. 2007. PMID: 17392718 Clinical Trial.

4

Shed human enterocytes as a tool for the study of expression and function of intestinal drug-metabolizing enzymes and transporters.

Glaeser H, Drescher S, van der Kuip H, Behrens C, Geick A, Burk O, Dent J, Somogyi A, Von Richter O, Griese EU, Eichelbaum M, Fromm MF. Glaeser H, et al. Clin Pharmacol Ther. 2002 Mar;71(3):131-40. doi: 10.1067/mcp.2002.121370. Clin Pharmacol Ther. 2002. PMID: 11907487 Clinical Trial.

5

Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4.

Bhardwaj RK, Glaeser H, Becquemont L, Klotz U, Gupta SK, Fromm MF. Bhardwaj RK, et al. Among authors: glaeser h. J Pharmacol Exp Ther. 2002 Aug;302(2):645-50. doi: 10.1124/jpet.102.034728. J Pharmacol Exp Ther. 2002. PMID: 12130727

6

Impact of concentration and rate of intraluminal drug delivery on absorption and gut wall metabolism of verapamil in humans.

Glaeser H, Drescher S, Hofmann U, Heinkele G, Somogyi AA, Eichelbaum M, Fromm MF. Glaeser H, et al. Clin Pharmacol Ther. 2004 Sep;76(3):230-8. doi: 10.1016/j.clpt.2004.04.013. Clin Pharmacol Ther. 2004. PMID: 15371984

7

Effects of ursodeoxycholic acid on P-glycoprotein and cytochrome P450 3A4-dependent pharmacokinetics in humans.

Becquemont L, Glaeser H, Drescher S, Hitzl M, Simon N, Murdter TE, Heinkele G, Hofmann U, Schaefer C, Burk O, Verstuyft C, Eichelbaum M, Fromm MF. Becquemont L, et al. Among authors: glaeser h. Clin Pharmacol Ther. 2006 May;79(5):449-60. doi: 10.1016/j.clpt.2006.01.005. Epub 2006 Apr 11. Clin Pharmacol Ther. 2006. PMID: 16678547 Clinical Trial.

8

Increased absorption of digoxin from the human jejunum due to inhibition of intestinal transporter-mediated efflux.

Igel S, Drescher S, Mürdter T, Hofmann U, Heinkele G, Tegude H, Glaeser H, Brenner SS, Somogyi AA, Omari T, Schäfer C, Eichelbaum M, Fromm MF. Igel S, et al. Among authors: glaeser h. Clin Pharmacokinet. 2007;46(9):777-85. doi: 10.2165/00003088-200746090-00005. Clin Pharmacokinet. 2007. PMID: 17713975 Clinical Trial.

9

Animal models and intestinal drug transport.

Glaeser H, Fromm MF. Glaeser H, et al. Expert Opin Drug Metab Toxicol. 2008 Apr;4(4):347-61. doi: 10.1517/17425255.4.4.347. Expert Opin Drug Metab Toxicol. 2008. PMID: 18433341 Review.

10

Interaction of innovative small molecule drugs used for cancer therapy with drug transporters.

Mandery K, Glaeser H, Fromm MF. Mandery K, et al. Among authors: glaeser h. Br J Pharmacol. 2012 Jan;165(2):345-62. doi: 10.1111/j.1476-5381.2011.01618.x. Br J Pharmacol. 2012. PMID: 21827448 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters